Split-liver procedure and inflammatory response: Improvement by pharmacological preconditioning

Journal of Surgical Research

Volumn 168, Issue 1, 2011, Pages

  Von Heesen, Maximilian ^a   Hülser, Matthias ^a   Seibert, Katharina ^a   Scheuer, Claudia ^a   Dold, Stefan ^a   Kollmar, Otto ^a   Wagner, Mathias ^a   Menger, Michael D ^a   Schilling, Martin K ^a   Moussavian, Mohammed Reza ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

apoptosis; ICAM 1; IL 1; IL 6; inflammation; leukocytes; organ preservation; pharmacologic preconditioning; pretreatment; split liver; TNF ; vascular complications

Indexed keywords

ACETYLCYSTEINE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; GLYCINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; MELATONIN; PENTOXIFYLLINE; RECOMBINANT ERYTHROPOIETIN; SIMVASTATIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL INVASION; CELL VACUOLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE RELEASE; INFLAMMATION; LEUKOCYTE; LIVER CELL; LIVER GRAFT; LIVER TRANSPLANTATION; LUNG PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SPLIT LIVER TRANSPLANTATION;

ANIMALS; APOPTOSIS; CELL MOVEMENT; CYTOKINES; DEFEROXAMINE; DRUG THERAPY, COMBINATION; FEMALE; GLYCINE; GRAFT SURVIVAL; INFLAMMATION; LEUKOCYTES; LIVER TRANSPLANTATION; MALE; MODELS, ANIMAL; PENTOXIFYLLINE; PREOPERATIVE CARE; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 79955576862     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.01.036     Document Type: Article

References (54)

1. Yersiz H, Renz JF, Farmer DG, et al. One hundred in situ split-liver transplantations: A single-center experience. Ann Surg 2003;238:496.
2. SPLIT Research Group. Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes. Transplantation 2001;72:463.
3. Venick RS, Farmer DG, McDiarmid SV, et al. Predictors of survival following liver transplantation in infants: A single-center analysis of more than 200 cases. Transplantation 2010;89:600.
4. Cheng YF, Chen CL, Huang TL, et al. 3DCT angiography for detection of vascular complications in pediatric liver transplantation. Liver Transpl 2004;10:248.
5. Buell JF, Funaki B, Cronin DC, et al. Long-term venous complications after full-size and segmental pediatric liver transplantation. Ann Surg 2002;236:658.
6. Cronin DC 2nd, Schechter L, Lohman RF, et al. Advances in pediatric liver transplantation: Continuous monitoring of portal venous and hepatic artery flow with an implantable Doppler probe. Transplantation 2002;74:887.
7. Stringer MD, Marshall MM, Muiesan P, et al. Survival and outcome after hepatic artery thrombosis complicating pediatric liver transplantation. J Pediatr Surg 2001;36:888.
8. Duffy JP, Hong JC, Farmer DG, et al. Vascular complications of orthotopic liver transplantation: Experience in more than 4200 patients. J Am Coll Surg 2009;208:896.
9. Hashikura Y, Kawasaki S, Okumura N, et al. Prevention of hepatic artery thrombosis in pediatric liver transplantation. Transplantation 1995;60:1109.
10. Furuta S, Ikegami T, Nakazawa Y, et al. Hepatic artery reconstruction in living donor liver transplantation from the microsurgeon's point of view. Liver Transpl Surg 1997;3:388.
11. Salvalaggio PR, Modanlou KA, Edwards EB, et al. Hepatic artery thrombosis after adult living donor liver transplantation: The effect of center volume. Transplantation 2007;84:926.
12. Ferraz-Neto BH, Meira-Filho SR, Hidalgo R, et al. Correlation between graft arterial anatomy and biliary complications after liver transplantation. Transplant Proc 2007;39:2514.
13. Lorenzin D, Adani GL, Comuzzi C, et al. Comparison of two techniques of arterial anastomosis during adult cadaveric liver transplantation. Transplant Proc 2007;39:1879.
14. Nikeghbalian S, Kazemi K, Davari HR, et al. Early hepatic artery thrombosis after liver transplantation: Diagnosis and treatment. Transplant Proc 2007;39:1195.
15. Yamada T, Fujino T, Yuhki K, et al. Thromboxane A2 regulates vascular tone via its inhibitory effect on the expression of inducible nitric oxide synthase. Circulation 2003;108:2381.
16. Liu H, Drew P, Cheng Y, et al. Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model. J Thorac Cardiovasc Surg 2005;130:852.
17. Moussavian MR, von Heesen M, Menger MD. Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury. Langenbecks Arch Surg 2010. Jun 27 [Epub ahead of print].
18. Nishizawa H, Egawa H, Inomata Y, et al. Efficiency of pentoxifylline in donor pretreatment in rat liver transplantation. J Surg Res 1997;72:170.
19. Schemmer P, Bradford BU, Rose ML, et al. Intravenous glycine improves survival in rat liver transplantation. Am J Physiol 1999;276:924.
20. Drugas GT, Paidas CN, Yahanda AM, et al. Conjugated desferoxamine attenuates hepatic microvascular injury following ischemia/reperfusion. Circ Shock 1991;34:278.
21. Montero EF, Quireze C Jr. d'Oliveira DM. Bile duct exclusion from selective vascular inflow occlusion in rat liver: Role of ischemic preconditioning and N-acetylcysteine on hepatic reperfusion injury. Transplant Proc 2005;37:425.
22. Schmeding M, Neumann UP, Boas-Knoop S, et al. Erythropoietin reduces ischemia-reperfusion injury in the rat liver. Eur Surg Res 2007;39:189.
23. Kim SH, Lee SM. Cytoprotective effects of melatonin against necrosis and apoptosis induced by ischemia/reperfusion injury in rat liver. J Pineal Res 2008;44:165.
24. Lai IR, Chang KJ, Tsai HW, et al. Pharmacological preconditioning with simvastatin protects liver from ischemia-reperfusion injury by heme oxygenase-1 induction. Transplantation 2008;85:732.
25. Otte JB, de Ville de Goyet J, Reding R, et al. Pediatric liver transplantation: From the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr Surg Int 1998;13:308.
26. Menger MD, Vollmar B. Surgical trauma: Hyperinflammation versus immunosuppression? Langenbecks Arch Surg 2004;389:475.
27. Hildebrandt U, Kessler K, Plusczyk T, et al. Comparison of surgical stress between laparoscopic and open colonic resections. Surg Endosc 2003;17:242.
28. Schemmer P, Enomoto N, Bradford BU, et al. Activated Kupffer cells cause a hypermetabolic state after gentle in situ manipulation of liver in rats. Am J Physiol Gastrointest Liver Physiol 2001;280:1076.
29. Schemmer P, Enomoto N, Bradford BU, et al. Autonomic nervous system and gut-derived endotoxin: Involvement in activation of Kupffer cells after in situ organ manipulation. World J Surg 2001;25:399.
30. Colletti LM, Burtch GD, Remick DG, et al. The production of tumor necrosis factor α and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 1990;49:268.
31. Jaeschke H, Bautista AP, Spolarics Z, et al. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun 1991;15:277.
32. Colletti LM, Cortis A, Lukacs N, et al. Tumor necrosis factor upregulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998;10:182.
33. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007;35:757.
34. Schemmer P, Connor HD, Arteel GE, et al. Reperfusion injury in livers due to gentle in situ organ manipulation during harvest involves hypoxia and free radicals. J Pharmacol Exp Ther 1999;290:235.
35. Schemmer P, Schoonhoven R, Swenberg JA, et al. Gentle in situ liver manipulation during organ harvest decreases survival after rat liver transplantation: Role of Kupffer cells. Transplantation 1998;65:1015.
36. McGuire GM, Liu P, Jaeschke H. Neutrophil-induced lung damage after hepatic ischemia and endotoxemia. Free Radic Biol Med 1996;20:189.
37. Simeonova PP, Gallucci RM, Hulderman T, et al. The role of tumor necrosis factor-a in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol Appl Pharmacol 2001;177:112.
38. Menger MD, Vollmar B. Adhesion molecules as determinants of disease: From molecular biology to surgical research. Br J Surg 1996;83:588.
39. Vollmar B, Glasz J, Menger MD, et al. Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 1995;117:195.
40. Jaeschke H, Farhood A, Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 1991;261:1051.
41. Molnar RG, Wang P, Ayala A, et al. The role of neutrophils in producing hepatocellular dysfunction during the hyperdynamic stage of sepsis in rats. J Surg Res 1997;73:117.
42. Bautista AP. Chronic alcohol intoxication induces hepatic injury through enhanced macrophage inflammatory protein-2 production and intercellular adhesion molecule-1 expression in the liver. Hepatology 1997;25:335.
43. Gujral JS, Farhood A, Bajt ML, et al. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile ductligated mice. Hepatology 2003;38:355.
44. Vollmar B, Menger MD, Glasz J, et al. Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J Physiol 1994;267:786.
45. Fox-Robichaud A, Kubes P. Molecular mechanisms of tumor necrosis factor α-stimulated leukocyte recruitment into the murine hepatic circulation. Hepatology 2000;31:1123.
46. Jaeschke H, Farhood A, Fisher MA, et al. Sequestration of neutrophils in the hepatic vasculature during endotoxemia is independent of β 2 integrins and intercellular adhesion molecule-1. Shock 1996;6:351.
47. Liu P, Vonderfecht SL, Fisher MA, et al. Priming of phagocytes for reactive oxygen production during hepatic ischemia-reperfusion potentiates the susceptibility for endotoxin-induced liver injury. Circ Shock 1994;43:9.
48. Menger MD, Vollmar B. Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies. Transplant Proc 2007;39:485.
49. Dold S, Laschke MW, Lavasani S, et al. Simvastatin protects against cholestasis-induced liver injury. Br J Pharmacol 2009;156:466.
50. Moussavian MR, Slotta JE, Kollmar O, et al. Post-hypoxic cellular disintegration in glycine-preserved renal tubules is attenuated by hydroxyl radical scavengers and iron chelators. Langenbecks Arch Surg 2008;393:303.
51. Moussavian MR, Slotta JE, Kollmar O, et al. Hemoglobin induces cytotoxic damage of glycine-preserved renal tubules. Transpl Int 2007;20:884.
52. Le Minh K, Klemm K, Abshagen K, et al. Attenuation of inflammation and apoptosis by pre- and post-treatment of darbepoetin-α in acute liver failure of mice. Am J Pathol 2007;170:1954.
53. Thorley AJ, Ford PA, Giembycz MA, et al. Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J Immunol 2007;178:463.
54. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340:1081.